1.Effect and mechanism of fluorofenidone on organ fibrosis.
Hong MA ; Zhangzhe PENG ; Gaoyun HU ; Lijian TAO
Journal of Central South University(Medical Sciences) 2015;40(2):208-213
Fibrosis can occur in different organs with high incidence rate and great danger. It still lacks effective drugs for prevention of fibrosis. Fluorofenidone is a newly developed drug with anti-fibrotic activity, which provides a new hope for treating the progressive fibrotic diseases. Recent studies have shown that fluorofenidone is a multifunctional small molecule with anti-inflammatory, antioxidative and anti-apoptotic eff ects. It can inhibit the activation and proliferation of myofibroblasts, promote the degradation of extracellular matrix and regulate the cellular signal transmission. Fluorofenidone can be applied to attenuate the progression of renal, hepatic and pulmonary fibrosis.
Apoptosis
;
Extracellular Matrix
;
Fibrosis
;
Humans
;
Kidney
;
pathology
;
Liver Cirrhosis
;
Pulmonary Fibrosis
;
Pyridones
;
pharmacology
;
Signal Transduction
2.In vitro interaction of deferiprone with cellular membrane transporters of hOCTs and hOAT1.
Si-si KONG ; Mei-juan TU ; Xi YANG ; Lei HU ; Xun-shi ZHAO ; Hui ZHOU ; Su ZHENG ; Hui-di JIANG
Journal of Zhejiang University. Medical sciences 2014;43(2):129-134
OBJECTIVETo develop a LC-MS/MS method for determination of deferiprone in cell lysate and to study the potential interaction between deferiprone and hOCTs or hOAT1 transporters in vitro.
METHODSThe determination was performed on an Agilent Eclipse Plus C18 column(3.5 μm, 2.1 mm×50 mm).The gradient mobile phase was composed of solvent A:0.1% formic acid in water, and B:0.1% formic acid in acetonitrile. The mass spectrometer with an electrospray interface was operated in positive ion mode with multiple reaction monitoring (MRM) scan mode monitored the ion pair of deferiprone at m/z 140→96, or phenacetin at m/z 180→110. The effects of deferiprone on the accumulation of typical substrates of hOCTs and hOAT1 were evaluated by MDCK-hOCTs and MDCK-hOAT1 cells respectively. The accumulation of deferiprone was also investigated in MDCK-hOCTs cells and mock cells with or without typical inhibitors.
RESULTSThe standard curve was linear over the range of 5-300 nmol/L. The assay recovery of deferiprone was above 94%, and the intra-day precision (RSD) was less than 2.0%. The accumulation of MPP(+) in MDCK-hOCTs cells with 300 μmol/L deferiprone were 73.5%, 87.1% and 70.4%, respectively. The uptake of deferiprone in MDCK-hOCTs and mock cells did not show significant difference. Deferiprone of 100 μmol/L did not significantly affect the accumulation of 6-CF in MDCK-hOAT1 cell.
CONCLUSIONThe method is sensitivity and suitable for the determination of deferiprone in cell lysate. Deferiprone can significantly inhibit hOCT1 and hOCT3, but has no effects on hOCT2 and hOAT1. hOCTs may not play a major role in the transport of deferiprone.
Animals ; Chromatography, Liquid ; Dogs ; Humans ; Madin Darby Canine Kidney Cells ; Organic Anion Transporters ; drug effects ; Pyridones ; pharmacology ; Tandem Mass Spectrometry
3.Effects of H3K27 methylation inhibitor EPZ005687 on apoptosis, proliferation and cell cycle of U937 cells and normal CD34 positive cells.
Shan-Hao TANG ; Ren-Zhi PEI ; Jun-Xia MA ; Pei-Sheng ZHANG ; Xu-Hui LIU ; Xiao-Hong DU ; Dong CHEN ; Ke-Ya SHA ; Jun-Jie CAO ; Shuang-Yue LI
Journal of Experimental Hematology 2014;22(6):1561-1566
The aim of this study was to investigate the effects of H3K27 methylation inhibitor EPZ005687 on the apoptosis, proliferation and cell cycle of U937 cells and normal CD34⁺ cells. The U937 cells and normal CD34⁺ cells were treated with different concentration of EPZ005687 at different time points. The apoptosis rate was determined by Annexin V/PI staining. The cell proliferation and cell cycle was determined using WST-1 assay and 7-AAD assay, respectively. The activity of H3K27 methylation was detected by chemiluminescent immunoassay. The results showed that the EPZ005687 induced an obvious apoptosis of U937 cells. The apoptotic rate was 3.96% ± 0.79%,5.74% ± 0.73%,13.34% ± 1.77% and 25.24% ± 2.55% in U937 cells treated with 0.5, 1, 5 and 10 µmol/L EPZ005687 for 48 hours, respectively. However, EPZ005687 had rare effect on normal bone marrow(NBM) CD34⁺ cells. The apoptotic rate was 3.64% ± 0.62%,4.28% ± 0.99%,6.18% ± 1.19% and 7.56% ± 1.34% after U937 cells were treated with 0.5, 1, 5 and 10 µmol/L EPZ005687 for 48 hours, respectively. EPZ005687 inhibited obviously the proliferation of U937 cells but had weak effect on the proliferation of NBMCD34⁺ cells. The inhibitory effect of EPZ005687 on U937 cells was time-dependent after treated with 0.5, 1, 5 and 10 µmol/L EPZ005687 from 12 to 96 hours. EPZ005687 induced G1 phase blocking (G1%, 64.18% ± 13.27% vs 49.43% ± 12.54%) and decreased the percentage of cells in S phase (9.67% ± 2.61% vs15.26% ± 5.58%) in U937 cells. However, EPZ005687 had no effect on the cell cycle of NBMCD34⁺ cells. In addition, EPZ005687 produced obviously depletion of H3K27 methylation in U937 cells (P < 0.05), but hardly had effect on the H3K27 methylation of NBMCD34⁺ cells. It is concluded that the EPZ005687 inhibites proliferation, induces apoptosis and cell cycle blocking in G1 phase in leukemia cells. This agent may have potential value in clinical application.
Antigens, CD34
;
metabolism
;
Apoptosis
;
drug effects
;
Cell Cycle
;
drug effects
;
Cell Proliferation
;
drug effects
;
Humans
;
Indazoles
;
pharmacology
;
Methylation
;
Pyridones
;
pharmacology
;
U937 Cells
4.Study on conditions of seed germination of Cistanche.
Xue-Yi QIAO ; Hua-Lei WANG ; Yu-Hai GUO
China Journal of Chinese Materia Medica 2007;32(18):1848-1850
OBJECTIVETo study the effect of fluridone concentration, stimulating period, temperature and salt on the seed germination of three species of Cistanche.
METHODThe seeds were cultured in Petri dish, and the germination percentage was counted.
RESULTThe highest germination percentage was observed in Cistanche tubulosa, C. deserticola, C. sala seeds pre-treated by 0.1 mg x L(-1) fluridone for 24-29 h. The optimal temperature for the seeds germination of three species of Cistanche was at 20-30 degrees C, and the seeds did not germinate at sub-or supraoptimal temperatures (5 and 35 degrees C). The salt tolerance of C. sala seeds was strong, and the critical value of NaCl concentration was 0.04 mol x L(-1). By contrast, C. tubulosa and C. deserticola seeds were more sensitive to the salt stress, the critical value of NaCl concentration was 0.02 mol x L(-1).
CONCLUSIONThe optimal germination condition and the method of testing germination percentage of three species of Cistanche seeds are as follow: the seeds are pre-treated by 0.1 mg x L(-1) fluridone for 24 h and then cultured at 20-30 degrees C in salt solution which concentration is lower than 0.02 mol x L(-1).
Cistanche ; classification ; growth & development ; Germination ; drug effects ; physiology ; Plants, Medicinal ; growth & development ; Pyridones ; pharmacology ; Seeds ; growth & development ; Sodium Chloride ; pharmacology ; Species Specificity ; Temperature
5.Progress in the studies on small molecule IGF-1R inhibitors.
Yan XU ; Guang-shu WANG ; Wei SUN ; Xiao-hong YANG ; Li-bao XU
Acta Pharmaceutica Sinica 2008;43(10):979-984
The importance of insulin-like growth factor 1 receptor (IGF-1R) signaling in malignant behaviour of tumour cells is well established. Inhibiting the activity of IGF-1R may result in striking apoptosis in malignant cells growing. IGF-1R antibodies which are currently in phase I and II clinical trials and several IGF-IR TKIs have preclinically been characterized. This review describes recent developments of small molecule tyrosine kinase inhibitors.
Animals
;
Apoptosis
;
drug effects
;
Benzimidazoles
;
pharmacology
;
Catechin
;
analogs & derivatives
;
pharmacology
;
Cell Line, Tumor
;
Humans
;
Neoplasms
;
pathology
;
Piperazines
;
pharmacology
;
Protein Kinase Inhibitors
;
pharmacology
;
Pyridones
;
pharmacology
;
Pyrimidines
;
pharmacology
;
Pyrroles
;
pharmacology
;
Receptor, IGF Type 1
;
antagonists & inhibitors
;
chemistry
;
metabolism
;
Signal Transduction
6.Pirfenidone diminishes SiO2 induced lung fibrosis in rats.
Ling-Fang FENG ; Zhen-Yu JIA ; Li-Jin ZHU ; Li JU ; Jun-Qiang CHEN ; Zhao-Qiang JIANG ; Ri-Ping CHEN ; Zhen MA ; Xing ZHANG
Chinese Journal of Industrial Hygiene and Occupational Diseases 2010;28(10):772-775
OBJECTIVEto investigate whether pirfenidone (PFD) presents the antifibrotic effect in silicosis of rats.
METHODSSD rats were randomly divided into five groups: the non-treat group, the normal saline group, the normal saline + PFD group, the SiO2 group, the SiO2 + PFD group. Rats except in the non-treat group were intratracheally instilled with SiO2 (25 mg/ml) or normal saline. The rats in normal saline + PFD group and the SiO2 + PFD group were given PFD (50 mg/kg) orally the next day after instillation and throughout the study. Rats were respectively sacrificed 7, 21, 42 days after instillation. The pathology changes were evaluated by Haematoxylin-eosin (HE), Van Gieson and Foot staining, and the hydroxyproline (HYP) content of pulmonary tissue was determined.
RESULTScompared with the SiO2 group, PFD could relieve the fibrotic changes in the lungs of rats. The fibrotic degree in silicotic lesions of lungs was lower in the SiO2 + PFD group than that of SiO2 group. The HYP content in the lungs of the SiO2 + PFD group [(0.75 ± 0.12) mg/g] was significantly lower than that of the SiO2 group [(1.19 ± 0.17) mg/g] at 42 days after instillation (P < 0.05).
CONCLUSIONthese data support that PFD has an antifibrotic effect against SiO2 induced lung fibrosis in rats, Which appears to be changing collagen accumulation and inhibiting pulmonary fibrosis.
Animals ; Hydroxyproline ; metabolism ; Lung ; drug effects ; metabolism ; pathology ; Male ; Pulmonary Fibrosis ; drug therapy ; metabolism ; pathology ; Pyridones ; pharmacology ; therapeutic use ; Rats ; Rats, Sprague-Dawley ; Silicon Dioxide ; adverse effects
7.Effect of Iron-Chelator Deferiprone on the In Vitro Growth of Staphylococci.
Choon Mee KIM ; Sung Heui SHIN
Journal of Korean Medical Science 2009;24(2):289-295
The standard iron-chelator deferoxamine is known to prevent the growth of coagulase-negative staphylococci (CoNS) which are major pathogens in iron-overloaded patients. However, we found that deferoxamine rather promotes the growth of coagulase-positive Staphylococcus aureus. Accordingly, we tested whether deferiprone, a new clinically-available iron-chelator, can prevent the growth of S. aureus strains as well as CoNS. Deferiprone did not at least promote the growth of all S. aureus strains (n=26) and CoNS (n=27) at relatively low doses; moreover, it could significantly inhibit the growth of all staphylococci on non-transferrin-bound-iron and the growth of all CoNS on transferrin-bound iron at relatively high doses. At the same doses, it did not at least promote the growth of all S. aureus strains on transferrin-bound-iron. These findings indicate that deferiprone can be useful to prevent staphylococcal infections, as well as to improve iron overload, in iron-overloaded patients.
Deferoxamine/pharmacology
;
Humans
;
Iron/metabolism
;
Iron Chelating Agents/*pharmacology
;
Iron Overload/metabolism
;
Microbial Sensitivity Tests
;
Pyridones/*pharmacology
;
Staphylococcus/*drug effects/growth & development
;
Staphylococcus aureus/drug effects/growth & development
;
Transferrin/metabolism
8.Therapeutic effect of enhancer of Zeste homolog 2 inhibitor GSK343 on periodontitis by regulating macrophage differentiation.
West China Journal of Stomatology 2017;35(3):264-268
OBJECTIVETo explore the therapeutic effect of enhancer of Zeste homolog 2 (EZH2) inhibitor GSK343 on periodontitis by regulating microphage differentiation.
METHODSMacrophage RAW264.7 cells were divided into the blank (A group), control (B group), lipopolysaccharide (LPS) stimulation (C group), and LPS+GSK343 (D group) groups. Phenotype transformations was determined through Western blot analysis and enzyme-linked immunosorbent assay by detecting the differentiation of phenotypic biological markers, including tumor necrosis factor-α (TNF-α), inducible nitric oxide synthase (iNOS), interleukin-10 (IL-10), and Arginase-1 (Arg-1). Metergasis was identified by performing a phagocytosis test on Escherichia coli (E. coli).
RESULTSMacrophage RAW264.7 cells produced classical phenotypic biomarkers (M1) TNF-α and iNOS under LPS stimulation. The expression levels of IL-10 and Arg-1 increased after adding GSK343 into the culture medium. GSK343 also induced the conversion of M1 macrophages into M2 macrophages. Macrophage RAW264.7 cells exerted a phagocytic effect on E. coli, and this effect was enhanced after adding LPS into the culture medium. GSK343 regulated the macrophage RAW264.7 phagocytosis of E. coli.
CONCLUSIONSGSK343 possibly participates in the regulation of macrophage differentiation and, consequently, in the latent treatment of periodontitis.
Arginase ; Cell Differentiation ; Enhancer of Zeste Homolog 2 Protein ; Enzyme Inhibitors ; pharmacology ; Enzyme-Linked Immunosorbent Assay ; Escherichia coli ; Indazoles ; pharmacology ; Interleukin-10 ; Lipopolysaccharides ; Macrophages ; Nitric Oxide Synthase Type II ; Periodontitis ; Phagocytosis ; Pyridones ; pharmacology ; Tumor Necrosis Factor-alpha
9.Pirfenidone alleviates urethral stricture following urethral injury in rats by suppressing TGF-β1 signaling and inflammatory response.
Zhong LI ; Xu HUANG ; Shou Feng CHEN ; Zhi Jian ZHANG ; Xin LIANG ; Hai Hui LI ; Lei QIN ; Yuan Yuan GUO
Journal of Southern Medical University 2022;42(3):411-417
OBJECTIVE:
To investigate the effect of pirfenidone for reducing urethral stricture following urethral injury in rats and explore the possible mechanism.
METHODS:
Thirty male SD rats were randomly assigned into negative control group, positive control group and pirfenidone group (n=10). In pirfenidone and positive control groups, the rats were subjected to incision of the posterior urethral cavernous body followed by daily intraperitoneal injection of pirfenidone (100 mg/kg) and an equivalent volume of solvent, respectively. The rats in the negative control group were given intraperitoneal injections of solvent without urethral injury. At two weeks after modeling, retrograde urethrography was performed for observing urethral stricture, and the injured urethral tissues were harvested for HE staining, Masson staining, immunohistochemical staining and Western blotting for detecting the protein expressions of α-SMA and TGF-β1. The mRNA expressions of the inflammatory factors TNF-α, IL-6, and IL-1β were detected using qRT-PCR.
RESULTS:
The body weight of the rats in pirfenidone group was significantly decreased compared with that in the other two groups (P < 0.05). Retrograde urethrography showed significant narrowing of the urethra in the positive control group but not in the pirfenidone group. HE staining of the injured urethral tissues showed obvious proliferation of urethral epithelial cells with narrow urethral cavity and increased inflammatory cells in positive control group. The pathological findings of the urethra were similar between pirfenidone group and the negative control group. Masson staining revealed obviously reduced collagen fibers and regular arrangement of the fibers in pirfenidone group as compared to the positive control group. Compared with those in the negative control group, the expressions of α-SMA and TGF-β1 were significantly increased in the positive control group, and pirfenidone treatment significantly inhibited their expressions (P < 0.05 or 0.01). Pirfenidone also significantly inhibited the mRNA expressions of TNF-α, IL-6, and IL-1β in the injured urethral tissue (P < 0.05 or 0.01).
CONCLUSION
Pirfenidone can prevent urethral fibrosis and stricture after urethral injury possibly by inhibiting the TGF-β1 pathway and inflammatory response.
Animals
;
Female
;
Humans
;
Interleukin-6/metabolism*
;
Male
;
Pyridones/pharmacology*
;
RNA, Messenger/metabolism*
;
Rats
;
Rats, Sprague-Dawley
;
Solvents
;
Transforming Growth Factor beta1/metabolism*
;
Tumor Necrosis Factor-alpha/metabolism*
;
Urethral Stricture/pathology*
10.Effects of ABA and its biosynthetic inhibitor fluridone on accumulation of penolic acids and activity of PAL and TAT in hairy root of Salvia miltiorrhiza.
Beimi CUI ; Zongsuo LIANG ; Yan LIU ; Fenghua LIU ; Jianguo ZHU
China Journal of Chinese Materia Medica 2012;37(6):754-759
OBJECTIVETo study the function of ABA and fluridone on the contents of penolic acids and two key synthetases (PAL and TAT).
METHODConducted 4 different concentrations in the hairy root of Salvia miltiorrhiza after culturing 18 days and treated with fluridone. One day later, harvested the hairy root and measured the activity of PAL and TAT; Treatment for 6 days, gathered and determined the contents of phenolic acids.
RESULTIn certain concentration of ABA, lower ABA could induced the production of growth and higher ABA inhibitor the growth in hairy roots of S. miltiorrhiza; ABA induced the accumulation of caffeic acid considerably, and the effect on the contents of coffee acid show positive correlation; As for the RA and LAB, the low dosage of ABA simulated the production and higher ABA inhibited the production of them; the ABA biosynthetic inhibitor fluridone can decreases ABA's the effect; The different of ABA activated the activity of PAL and TAT, but the impact were discriminating, when treatment with ABA and fluridone, the inducing were declined.
CONCLUSIONABA induced the accumulation of.
Abscisic Acid ; antagonists & inhibitors ; metabolism ; pharmacology ; Antioxidants ; analysis ; metabolism ; Biomass ; Caffeic Acids ; analysis ; metabolism ; Herbicides ; pharmacology ; Hydroxybenzoates ; analysis ; metabolism ; Medicine, Chinese Traditional ; Phenylalanine Ammonia-Lyase ; drug effects ; metabolism ; Plant Roots ; drug effects ; enzymology ; growth & development ; Pyridones ; pharmacology ; Salvia miltiorrhiza ; drug effects ; enzymology ; growth & development ; Time Factors ; Tyrosine Transaminase ; drug effects ; metabolism